NICOLE DAVIA: Open Payments
NPI 1598709230 · WASHINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$276 in 11 payments from 6 companies in 2025. Trend: 2023 $189 · 2024 $484 · 2025 $276
Food & beverage: $276
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 3 | $96 |
| Novartis Pharmaceuticals Corporation | 2 | $56 |
| Janssen Biotech, Inc. | 2 | $45 |
| PFIZER INC. | 2 | $35 |
| GENZYME CORPORATION | 1 | $22 |
| Tempus AI, Inc | 1 | $21 |
Products named: KEYTRUDA, KISQALI, ERLEADA, Fabhalta, SARCLISA, XT CDX, RYBREVANT, BOSULIF.
Industry payments across NC — which companies pay providers there.
